FOLD logo
FOLD NASDAQ US

Amicus Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Sito web · IPO Mag 2007
$14,44
▲ +$0,00 (+0,00%)
Vol. 3.0M
5
Punteggio di Qualità
fail
Cap. mercato
$4.4B
ROE
-6,8%
Margine
-2,4%
D/E
170,11
Beta
0,41
52W
$6–$14

Consenso Wall Street

14 analisti · Apr 2026
2
Acquisto forte
4
Compra
8
Mantieni
0
Vendi
0
Vendita forte
42,9%
Rating Compra

Grafico dei Prezzi

Titoli simili

TGTX
TG Therapeutics Inc
P/E 10,6
$4.7B
APLS
Apellis Pharmaceuticals Inc
P/E 70,7
$3.2B
IMVT
Immunovant Inc
$5.1B
APGE
Apogee Therapeutics Inc
$5.2B
DNTH
Dianthus Therapeutics Inc
$1.8B
VKTX
Viking Therapeutics Inc
$4.0B
ACAD
ACADIA Pharmaceuticals Inc
P/E 17,3
$4.5B
SYRE
Spyre Therapeutics Inc
$2.5B
LEGN
Legend Biotech Corp
$4.0B

Utili

Tasso di battuta: 50,0%
Trimestre EPS Stimato EPS Effettivo Sorpresa
Dic 2025 $0,09 $0,01 $-0,08
Set 2025 $0,04 $0,06 +$0,02
Giu 2025 $-0,12 $-0,07 +$0,05
Mar 2025 $-0,06 $-0,07 $-0,01

Ricavi e utili trimestrali

Trimestre 2024-0… 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Ricavi — $149.7M $125.2M $154.7M $169.1M $185.2M
Utile netto — $14.7M -$21.7M -$24.4M $17.3M $1.7M

Trend fondamentali

Metrica 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -19.8% -19.8% -19.8% -19.8% -6.8% -6.8%
P/E (TTM) — — — — — —
Net Margin -15.8% -6.7% -6.7% -6.7% -2.4% -2.4%
Gross Margin 90.2% 90.4% 90.4% 90.4% 89.8% 89.8%
D/E Ratio 191.54 191.54 191.54 191.54 170.11 170.11
Current Ratio 3.21 3.21 3.21 3.21 2.99 2.99

Rapporti chiave

ROA (TTM)
-1,7%
P/S (TTM)
7,36
P/B
14,5
EPS (TTM)
$-0,05
CF/Share
$-0,57
Crescita ricavi 3A
+20,0%
52W High
$14,36
52W Low
$5,51
$5,51 Intervallo 52 settimane $14,36

Salute finanziaria

Flusso di cassa libero
$16.0M
Debito netto
$228.4M
Liquidità
$214.0M
Debito totale
$442.4M
Aggiornato al Dic 31, 2025

Як FOLD виглядає на тлі конкурентів у Biotechnology?

Група порівняння: Micro-cap Biotechnology (All) · 528 компаній

FOLD AAPG ABEO ABOS ABP

Оцінка FOLD vs аналоги Biotechnology

P/E
—
▼ 0% sotto peer (18,8)
vs Peer
vs Settore
Sottovalutato
P/S
7,4
▼ 43% sotto peer (12,9)
vs Peer
vs Settore
Sottovalutato
P/B
14,5
▲ 490% sopra peer (2,5)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼ 0% sotto peer (0,0%)
vs Peer
vs Settore
Rendimento basso

Прибутковість FOLD vs аналоги Biotechnology

ROE
-6,8%
▲ 90% sopra peer (-67,3%)
vs Peer
vs Settore
Top livello
Net margin
-2,4%
▲ 99% sopra peer (-286,8%)
vs Peer
vs Settore
Sotto media
Валова маржа
89,8%
▲ 14% sopra peer (78,6%)
vs Peer
vs Settore
Debole
ROA
-1,7%
▲ 96% sopra peer (-46,7%)
vs Peer
vs Settore
Top livello

Фінансове здоровʼя FOLD vs аналоги Biotechnology

D/E ratio
170,1
▼ 0% sotto peer (0,0)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
3,0
▼ 33% sotto peer (4,4)
vs Peer
vs Settore
Liquidità bassa
Beta
0,4
▼ 58% sotto peer (1,0)
vs Peer
vs Settore
Più volatile

Радар фундаменталів FOLD

FOLD Mediana peer Industria

FOLD прибутковість vs борг

Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio

FOLD vs аналоги: ключові метрики

Attività insider

Neutral
Acquisti
0
Vendite
0
CAMPBELL BRADLEY LEWIS
Chief Executive Officer · Mar 02
22500 shs
CAMPBELL BRADLEY LEWIS
Chief Executive Officer · Gen 20
75000 shs
CAMPBELL BRADLEY LEWIS
Chief Executive Officer · Gen 20
75000 shs
Ultimo 90 giorni

Principali azionisti

Top 5: 33,06%
Blackrock Inc.
10,36%
$468.7M
Vanguard Group Inc
9,46%
$428.0M
HBK Investments L P
4,86%
$219.8M
State Street Corporation
4,72%
$213.7M
Pentwater Capital Managemen…
3,66%
$165.7M
Aggiornato al Dic 31, 2025

Ultime notizie

Samsung Guida Ancora — Ma i Rivali Pieghevoli Stanno Recuperando Rapidamente
Yahoo Finance · Apr 05
Meta aumenta gli investimenti nel data center AI del West Texas di …
CNBC · Mar 26
Come le Finali NCAA si svolgono, la NY Fed evidenzia il pedaggio …
CNBC · Mar 25
Coinbase Global Inc (COIN)’s Stablecoin Revenue Could Grow Sevenfold
Yahoo Finance · Mar 20